Cantourage Group SEXTER:HIGH -1.60%29 Quick Ratio is 7.63 as of Jun. 2025, which is 16% below its 10-year median of 9.10. GuruFocus rates XTER:HIGH with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 994 Drug Manufacturers companies, Cantourage Group SE ranks better than 93.06% on this metric.
Cantourage Group SE has a quick ratio of 7.63. It generally indicates good short-term financial strength.
The historical rank and industry rank for Cantourage Group SE's Quick Ratio or its related term are showing as below:
XTER:HIGH'
s Quick Ratio Range Over the Past 10 Years
Min: 2.01 Med: 9.1 Max: 53.94
Current: 7.63
During the past 5 years, Cantourage Group SE's highest Quick Ratio was 53.94. The lowest was 2.01. And the median was 9.10.
XTER:HIGH's Quick Ratio is ranked better than 93.06% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs XTER:HIGH: 7.63
Cantourage Group SE (XTER:HIGH) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Cantourage Group SE Quick Ratio Related Terms
Cantourage Group SE Quick Ratio Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:HIGH vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Cantourage Group SE's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cantourage Group SE (XTER:HIGH) has a Quick Ratio of 7.63 as of Jun. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Cantourage Group SE and its competitors. This is 16% below median its historical median of 9.10. Over the past decade, Cantourage Group SE's Quick Ratio has ranged from 2.01 to 53.94. According to the industry distribution chart, Cantourage Group SE ranks #69 out of 994 companies in the Drug Manufacturers industry, placing it in the top 6.9%.
Is Cantourage Group SE's Quick Ratio too high?
Cantourage Group SE's current Quick Ratio of 7.63 is 16% below median its 10-year median of 9.10. Over the past 10 years, this metric has ranged from a low of 2.01 to a high of 53.94. The Drug Manufacturers industry median Quick Ratio is 1.45. Cantourage Group SE's value of 7.63 is 426.2% above this industry median. Based on the distribution chart, Cantourage Group SE ranks #69 out of 994 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cantourage Group SE has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #69 out of 994 companies for Quick Ratio. This places Cantourage Group SE in the top 7% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Cantourage Group SE's value of 7.63 is 426.2% above this benchmark. Historically, Cantourage Group SE's own Quick Ratio has ranged from 2.01 to 53.94 over the past decade. While the company's 10-year median is 9.10 vs. the industry median of 1.45, Cantourage Group SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cantourage Group SE's current Quick Ratio of 7.63 is 426.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current Quick Ratio is 7.63, which is 16% below median its own 10-year median of 9.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Quick Ratio of 7.63. The current Quick Ratio is 7.63, which is 16% below median its 10-year median of 9.10 and 426.2% above the Drug Manufacturers industry median of 1.45. Cantourage Group SE's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Quick Ratio is 7.63 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
29GF Score
Get the complete analysis for XTER:HIGH
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:HIGH has been successfully added to your 
